{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:32:27Z","timestamp":1755225147919,"version":"3.43.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study evaluated C-reactive protein (CRP) in hospitalized patients with bladder cancer (BC) and explored the predictive value of CRP for venous thromboembolism (VTE), combining CRP and D-dimer (D-D) levels to improve the ability to predict the risk of VTE in BC patients, thereby better guiding clinical prevention and treatment of this disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Clinical data from 4,438 patients with BC admitted between January 2015 and December 2020 were reviewed. After screening, 2,164 patients remained.52 VTE cases were identified, and 104 matched controls were selected (1:2 ratio). Conditional logistic regression, receiver operating characteristic (ROC) curve analysis, stratified analysis, and interaction tests were conducted to assess predictive performance and control for confounding bias.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Conditional logistic regression analysis indicated that elevated CRP and D-D levels were associated with higher risk of VTE in hospitalized patients with BC. Moreover, the areas under the ROC curves were 0.734 for CRP, 0.817 for D-D, and 0.865 for the combined model, indicating that the combined model offers superior predictive performance. Stratified and interaction analyses further revealed that the predictive value of CRP and D-D levels was influenced by the infection status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Elevated CRP and D-D levels may be potential indicators of VTE in BC patients. Their combined use improves predictive accuracy, and their predictive value may be better in non-infected patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1652139","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T05:36:08Z","timestamp":1755063368000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated C-reactive protein and D-dimer to predict venous thromboembolism in patients with bladder cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Bo","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonghe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huitang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yandong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoju","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yankui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2025.03.019","article-title":"The incidence and risk of venous thromboembolism in patients with active Malignancy and isolated superficial venous thrombosis: a systematic review and meta-analysis (the IROVAM-iSVT review)","volume":"23","author":"Bailey","year":"2025","journal-title":"J Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12959-025-00719-7","article-title":"Cancer-associated venous thromboembolism: a comprehensive review","volume":"23","author":"Wan","year":"2025","journal-title":"Thromb J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-170146","article-title":"Thromboembolism in patients with bladder cancer: incidence, risk factors and prevention","volume":"4","author":"Zareba","year":"2018","journal-title":"Bladder Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e22945","DOI":"10.7759\/cureus.22945","article-title":"Venous thromboembolism rate in patients with bladder cancer according to the type of treatment: A systematic review","volume":"14","author":"Abdullah","year":"2022","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216243","article-title":"COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms","volume":"76","author":"Loo","year":"2021","journal-title":"Thorax"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1002652","article-title":"C-reactive protein, immunothrombosis and venous thromboembolism","volume":"13","author":"Dix","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1616253","article-title":"Editorial: Inflammation and immune factors in venous thromboembolism","volume":"16","author":"Grover","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14149","article-title":"Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis","volume":"16","author":"Di Nisio","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00345-019-02705-x","article-title":"Perioperative venous thromboembolism prophylaxis in prostate cancer surgery","volume":"38","author":"Klaassen","year":"2020","journal-title":"World J Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.123.318779","article-title":"Updates in the incidence, pathogenesis, and management of cancer and venous thromboembolism","volume":"43","author":"Girardi","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2023.08.005","article-title":"Predictors of cancer in patients with acute pulmonary embolism","volume":"230","author":"Felix","year":"2023","journal-title":"Thromb Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"18031","DOI":"10.1038\/nrdp.2018.31","article-title":"Pulmonary embolism","volume":"4","author":"Starling","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1002\/onco.13584","article-title":"Treatment of cancer-associated venous thromboembolism with low-molecular-weight heparin or direct oral anticoagulants: patient selection, controversies, and caveats","volume":"26","author":"O\u2019Connell","year":"2021","journal-title":"Oncologist"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2023.03.017","article-title":"Inflammasome signaling, thromboinflammation, and venous thromboembolism","volume":"8","author":"Potere","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.3390\/ijms232113176","article-title":"Immunothrombosis and the role of platelets in venous thromboembolic diseases","volume":"23","author":"Heestermans","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02126","article-title":"How C-reactive protein structural isoforms with distinctive bioactivities affect disease progression","volume":"11","author":"Rajab","year":"2020","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1425168","article-title":"C-reactive protein: structure, function, regulation, and role in clinical diseases","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1055\/a-2495-1350","article-title":"C-reactive protein, genetic susceptibility, and the long-term risk of venous thromboembolism in patients with past cancer","author":"Guan","year":"2024","journal-title":"Thromb Haemost"},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.trsl.2020.06.012","article-title":"Mechanisms and biomarkers of cancer-associated thrombosis","volume":"225","author":"Kim","year":"2020","journal-title":"Transl Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2018.1529734","article-title":"D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications","volume":"55","author":"Favresse","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283966","article-title":"How we manage a high D-dimer","volume":"109","author":"Franchini","year":"2024","journal-title":"Haematologica"},{"key":"B26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12885-025-13939-x","article-title":"Risk factors for in-hospital venous thromboembolism in patients with bladder cancer: A retrospective single-center study","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0269-5","article-title":"D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis","volume":"119","author":"Jara-Palomares","year":"2018","journal-title":"Br J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13234","article-title":"Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke","volume":"24","author":"Gon","year":"2017","journal-title":"Eur J Neurol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.11.116","article-title":"Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study","volume":"9","author":"Shen","year":"2017","journal-title":"J Thorac Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.3390\/jcm10225270","article-title":"Inflammatory markers and thromboembolic risk in patients with non-muscle-invasive bladder cancer","volume":"10","author":"Balan","year":"2021","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1055\/a-1661-0257","article-title":"Thromboinflammation as a driver of venous thromboembolism","volume":"41","author":"Gauchel","year":"2021","journal-title":"Hamostaseologie"},{"key":"B33","doi-asserted-by":"publisher","first-page":"180119","DOI":"10.1183\/16000617.0119-2018","article-title":"Cancer-associated thrombosis: the when, how and why","volume":"28","author":"Fernandes","year":"2019","journal-title":"Eur Respir Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1237729","article-title":"C-reactive protein: a target for therapy to reduce inflammation","volume":"14","author":"Rizo-T\u00e9llez","year":"2023","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12959-023-00526-y","article-title":"Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis","volume":"21","author":"Ding","year":"2023","journal-title":"Thromb J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0086","article-title":"Why C-reactive protein is one of the most requested tests in clinical laboratories","volume":"61","author":"Plebani","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13369","article-title":"C-reactive protein, obesity, and the risk of arterial and venous thrombosis","volume":"14","author":"Horvei","year":"2016","journal-title":"J Thromb Haemost"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17272","article-title":"Diagnosis and treatment of lower extremity venous thromboembolism: A review","volume":"324","author":"Chopard","year":"2020","journal-title":"Jama"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.02.025","article-title":"Procedure-specific risks of thrombosis and bleeding in urological non-cancer surgery: systematic review and meta-analysis","volume":"73","author":"Tikkinen","year":"2018","journal-title":"Eur Urol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1652139\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T05:36:08Z","timestamp":1755063368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1652139\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2025.1652139"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1652139","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"article-number":"1652139"}}